Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine. For over 25 years, TCT has been the center of cutting-edge educational content, showcasing the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation translates into improved patient care.


Target Audience

This symposium is designed for interventional cardiologists, radiologists, clinical cardiologists, scientists, vascular medicine specialists, cardiac and vascular surgeons, nurse practitioners, cath lab technicians, and other healthcare professionals with a special interest in the field of interventional and vascular medicine.

Needs Statement

TCT provides the latest evidence-based data, presented by leading physicians, nurses, and scientists, that will affect the practice of interventional cardiology and endovascular medicine. TCT showcases the practical applications of current and emerging techniques and technologies and an unparalleled diversity of Live Case presentations from universities and medical centers from around the world. In the field of interventional cardiology, only TCT combines the late-breaking science and practical education that physicians need to improve patient outcomes.

Activity Goals

The overall goal of this activity is to improve the competence and performance of our target audience by delivering cutting-edge educational content that showcases the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation will translate into improved patient care.

Learning Objectives

By the end of the symposium, participants should be able to:

  • Apply the results from important clinical trials and evidence-based medicine to guide the management of patients with atherosclerosis and structural heart disease
  • Incorporate new interventional technologies and procedures into the care of patients with complex coronary and endovascular disease
  • Integrate advances in diagnostic evaluation and therapeutics into the treatment of patients with carotid and peripheral arterial disease
  • Implement appropriate pharmacologic management in the care of patients undergoing diagnostic arteriography and interventional therapies before, during, and after catheterization
  • Identify new interventional technologies and propose appropriate applications for patients with cardiovascular disease

Disclosure Statement

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations and therefore does not compromise the scientific integrity of the educational activity.

Discussion of off-label product usage and/or off-label product use during live cases is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.

Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty in noncompliance with this policy are not permitted to participate in this activity.

CME Credit Claim

To claim your CME or CNE credits, please use the CRF Events app on your mobile device. The CRF Events app can be found in the App Store and Google Play Stores.

Successful completion requires a brief evaluation of each of the sessions attended and an evaluation of the TCT conference as a whole. Evaluations will address content, presentation, possible bias, and future educational needs.

For any CME or CNE related inquiry, please email .

Program Sponsorship and Support

This symposium is sponsored by the Cardiovascular Research Foundation and supported through educational grants from multiple commercial supporters. The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience.

To support this endeavor, the directors and co-directors of TCT create organizational and scientific committees to assist in the development and oversight of educational content for live cases, concurrent sessions, case reviews, abstract sessions, practical workshops, and scientific symposia. These sessions are developed without influence from commercial supporters.



Accredited status does not imply endorsement by the ANCC of any commercial products displayed in conjunction with this activity.

The TCT 2017 conference is not accredited for PharmD credit. All non-CME or non-CNE accreditation is made at the sole discretion of the specialty education provider.